|
|
|
|
|
Guiding role of EVLWI combined with ITBVI in septic shock with ARDS targeted oriented fluid replacement therapy |
Bai Ling-xiao, Gong Mei, Liu Guo-juan |
Intensive Care Unit, Inner Mongolia People′s Hospital, Huhhot 010017, China |
|
|
Abstract Objective To explore the guiding role of extravascular lung water index (EVLWI) combined with intrathoracic blood volume index (ITBVI) on target oriented fluid replacement therapy for the patients with septic shock and acute respiratory distress syndrome (ARDS). Methods Sixty patients with septic shock and ARDS were selected from April 2013 to May 2018 in our hospital. They were randomly divided into study group and control group, with 30 cases in each group. The patients in control group were given the target oriented fluid replacement therapy by monitoring central venous pressure (CVP), while the patients in study group were given the target oriented fluid replacement therapy by monitoring EVLWI and ITBVI by pulse indicator continuous cardiac output (PiCCO). The early recovery time of volume recovery and the standard-reaching rate of 6 h and 24 h between the 2 groups were compared, and the acute physiological and chronic health evaluation (APACHE)Ⅱ score, blood lactic acid (Lac), norepinephrine dosage and respiratory parameters (respiratory frequency, lung compliance, oxygenation index and end expiratory positive pressure level) were compared 1 d and 3 d after fluid replacement treatment, then the mechanical ventilation time, ICU time and 28-day mortality rate of the two groups were observed. Results The time of early volume recovery in the study group was (5.25±1.53) h, which was significantly shorter than that in the control group (6.54±1.86) h (P<0.05); and the 6-hour rate was 76.67%, which was significantly higher than that in the control group (46.67%, P<0.05). There was no significant difference in the 24-hour rate between the two groups (P>0.05). The APACHE Ⅱ score of critical patients in the study group was (20.37±3.89) after 3 days of treatment, while that in the control group was (23.16±4.05) after 3 days of treatment. There was a significant difference between the two groups after 3 days of treatment (P<0.05). There was no significant difference in respiratory parameters between the study group and the control group 1 day after treatment (P>0.05). The blood lactic acid, norepinephrine dosage, respiratory frequency and positive end-expiratory pressure levels in the study group after 3 days of treatment were (2.35±0.49) mmol/L,(0.61±0.13)μg/(kg·min), (18.47±3.61) beat/min and (5.04±1.09) cm H2O, respectively, which were all significantly lower than those on 1 d after treatment and [(8.57±1.86)mmol/L、(1.12±0.34)μg/(kg·min)、(28.79±6.14)beat/min、(9.18±2.74)cm H2O]those of control group[(7.58±1.52)mmol/L、(1.09±0.27)μg/(kg·min)、(27.16±5.88)beat/min、(8.17±2.31)cm H2O] (P<0.05). The pulmonary compliance and oxygenation index of the study group were (34.22±6.49) mL / cm H2O and (198.64±42.38) mm Hg, which were significantly higher than those of the control group [(27.18±5.65)mL/cm H2O、(148.27±38.69)mm Hg](P<0.05). There was no significant difference between the control group and the treatment group (P>0.05). The mechanical ventilation time and the ICU time of the study group were (6.55±1.84) d and (11.68±2.96) d, respectively, which were significantly shorter than those of the control group[(12.14±3.19)d、(17.26±4.09)d](P<0.05). The 28-day mortality in the study group was 20.0%, which was significantly lower than 46.67% in the control group (P<0.05). Conclusion EVLWI combined with ITBVI as a monitoring index in target oriented fluid replacement treatment of septic shock with ARDS patients can achieve recovery goals early, promote the recovery of the condition, improve the relevant parameters of respiratory, shorten the time of mechanical ventilation and stay at ICU time and reduce the 28-day mortality, which has a significant guiding effect of liquid management.
|
|
Corresponding Authors:
Gong Mei, E-mail: nmgongmei@163.com
|
|
|
|
[1]Gaudry S, Hajage D, Schortgen F, et al. Timing of renal support and outcome of septic shock and acute respiratory distress syndrome. A post hoc analysis of the AKIKI randomized clinical trial[J]. Am J Respir Crit Care Med, 2018, 198(1): 58-66.
[2]张友华,吕光宇,张磊,等. 早期液体复苏对脓毒性休克患者心肌损伤及预后的影响[J]. 现代中西医结合杂志, 2016,25(1):43-45.
[3]Sundaram SC, Salins SR, Kumar AN, et al. Intra-operative fluid management in adult neurosurgical patients undergoing intracranial tumour surgery: randomised control trial comparing pulse pressure variance (PPV) and central venous pressure (CVP)[J]. J Clin Diagn Res, 2016, 10(5): UC01-UC05.
[4]黄庆生,李燕,方明星,等. 脉搏指示连续心排血量监测技术在感染性休克合并急性呼吸窘迫综合征患者中的应用研究[J]. 中华医院感染学杂志, 2017, 27(19): 4371-4374.
[5]董家辉,莫泽珣,孙照琨,等. 急性生理和慢性健康状况Ⅱ评分对老年危重症患者住院病死率的验证研究[J]. 中华实用诊断与治疗杂志, 2017, 31(9): 868-871.
[6]高戈,冯喆,常志刚,等. 2012国际严重脓毒症及脓毒性休克诊疗指南[J]. 中华危重病急救医学, 2013, 25(8): 501-505.
[7]马孝忠. 临床呼吸内科学[M]. 天津. 天津科学技术出版社, 2012: 89-90.
[8]Schmidt EP, Overdier KH, Sun X, et al. Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2016, 194(4): 439-449.
[9]宋根红,房阁. 脓毒性休克患者早期目标导向性复苏的临床研究[J]. 临床急诊杂志, 2016, 17(4): 265-268, 273.
[10]Enghard P, Rademacher S, Nee J, et al. Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients[J]. Crit Care, 2015, 19: 36.
[11]黄山,邢柏,谭世峰,等. 脓毒性休克患者呼吸指数与血管外肺水指数的相关性[J]. 实用临床医药杂志, 2015, 19(1): 45-48.
[12]徐永昊,何为群,徐远达,等. 应用每搏输出量变异率和胸腔内血容量指数评估保留自主呼吸的机械通气感染性休克患者的容量反应性[J]. 中国呼吸与危重监护杂志, 2015, 14(4): 345-349.
[13]冯丽芝,肖昌武,周青山,等. PICCO容量监测在脓毒性休克合并急性呼吸窘迫综合征患者液体复苏中的临床应用[J]. 医学研究杂志, 2018, 47(3): 114-117.
[14]周森,邢柏,王小智,等. 胸腔内血容积指数和血管外肺水指数指导的液体管理方案在重症急性胰腺炎患者液体治疗中的应用价值[J]. 中国医药, 2015, 10(10): 1466-1471.
[15]Huber W, Henschel B, Schmid RM, et al. Comments on Zhang et al: Effectiveness of treatment based on PiCCO parameters in critically ill patients with septic shock and/or acute respiratory distress syndrome: a randomized controlled trial[J]. Intensive Care Med, 2015, 41(7): 1389-1390.
[16]夏炳杰,施善阳. 脉搏指示连续心排血量监测技术在感染性休克并急性呼吸窘迫综合征患者液体管理中的应用效果[J]. 实用心脑肺血管病杂志, 2016, 24(5): 100-102.
[17]高洪媛,邹新华,屈峰,等. PICCO监测技术联合重症超声在感染性休克患者液体复苏中的应用[J]. 临床肺科杂志, 2018, 23(2): 315-317. |
|
|
|